Related Experiment Video
Updated: Jul 3, 2026
12:36
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
Published on: March 14, 2020
Liver-kidney pathophysiological interrelationships in liver diseases
1Department of Internal Medicine, University of Florence School of Medicine, Florence, Italy. p.gentilini@dfc.unifi.it
Summary
This study explores kidney and liver interactions, detailing how liver disease impairs renal function through hemodynamic changes, metabolic issues like renal tubular acidosis, and organic damage from immune responses.
Area of Science:
- Nephrology
- Hepatology
- Internal Medicine
Background:
- Kidney and liver relationships are complex, with renal function during liver disease being a key area of research.
- Alterations in renal function due to liver disease manifest in several distinct ways.
Purpose of the Study:
- To delineate the mechanisms of renal impairment in liver disease.
- To categorize the different types of renal functional impairment observed.
Main Methods:
- Review of clinical and experimental research on kidney-liver interactions.
- Analysis of mechanisms including hemodynamic derangement, metabolic disturbances, and immunological responses.
Main Results:
- Renal functional impairment involves hemodynamic changes (e.g., decreased peripheral vascular resistance, hyperdynamic circulation) leading to renal ischemia.
- Metabolic damage includes tubular dysfunction and renal tubular acidosis (RTA), particularly type I, common in cholestatic disease.
- Organic impairment arises from immune responses, with immunocomplexes and cryoglobulins depositing in glomeruli, triggering inflammation.
Conclusions:
- Liver disease significantly impacts kidney function through multiple pathways.
- Understanding these mechanisms is crucial for managing patients with co-existing liver and kidney conditions.
- Further research into hepatorenal syndrome and associated renal pathologies is warranted.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:30Liver Physiology
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...